[{"studyInfo": {"title": "Safety & Efficacy Study of Study Drug (Eszopiclone) in Children and Adolescents With Attention-deficit/Hyperactivity Disorder - Associated Insomnia", "institution": "Sumitomo Pharma America, Inc.", "dates": {"start": null, "completion": "2011-07"}, "summary": null}, "participants": [{"groupName": "Pooled High Dose Eszopiclone", "dosage": 2, "size": null}, {"groupName": "Pooled Low Dose Eszopiclone", "dosage": 1, "size": null}, {"groupName": "Placebo", "dosage": null, "size": null}, {"groupName": "Total", "dosage": null, "size": null}]}, {"studyInfo": {"title": "Study of the Insomnia in Patients With Low Back Pain", "institution": "Duke University", "dates": {"start": null, "completion": "2010-09"}, "summary": null}, "participants": null}, {"studyInfo": {"title": "Long Term Safety Study of Study Drug (Eszopiclone) in Children and Adolescents With ADHD -Associated Insomnia", "institution": "Sumitomo Pharma America, Inc.", "dates": {"start": null, "completion": "2011-10"}, "summary": null}, "participants": [{"groupName": "2mg Eszopiclone (6-11yrs), 3mg Eszopiclone (12-17yrs)", "dosage": 2, "size": null}]}, {"studyInfo": {"title": "A Phase III Study of Eszopiclone in Patients With Insomnia (Study SEP 190-150)", "institution": "Eisai Inc.", "dates": {"start": null, "completion": "2010-05"}, "summary": null}, "participants": null}, {"studyInfo": {"title": "Randomized, Controlled, Double Blind Trial of Eszopiclone for Insomnia Associated With Schizophrenia", "institution": "Yale University", "dates": {"start": null, "completion": "2011-04"}, "summary": null}, "participants": null}, {"studyInfo": {"title": "Treatment of Insomnia and Glucose Metabolism", "institution": "University of Chicago", "dates": {"start": null, "completion": "2012-03"}, "summary": null}, "participants": null}, {"studyInfo": {"title": "A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly With Primary Chronic Insomnia", "institution": "Sumitomo Pharma America, Inc.", "dates": {"start": null, "completion": "2008-02"}, "summary": null}, "participants": null}, {"studyInfo": {"title": "A Phase II/III Study of SEP-190 (Eszopiclone) in Patients With Primary Insomnia (Study 190-126)", "institution": "Eisai Inc.", "dates": {"start": null, "completion": "2010-05"}, "summary": null}, "participants": null}, {"studyInfo": {"title": "Eszopiclone in the Treatment of Insomnia and Fibromyalgia", "institution": "Rutgers, The State University of New Jersey", "dates": {"start": null, "completion": "2009-03"}, "summary": null}, "participants": null}, {"studyInfo": {"title": "Treatment of Insomnia in Migraineurs", "institution": "MedVadis Research Corporation", "dates": {"start": null, "completion": "2008-09"}, "summary": null}, "participants": null}, {"studyInfo": {"title": "Sleep Loss and Mechanisms of Impaired Glucose Metabolism", "institution": "Brigham and Women's Hospital", "dates": {"start": null, "completion": "2008-08"}, "summary": null}, "participants": null}, {"studyInfo": {"title": "Treatment of Insomnia in Patients With Parkinson's Disease: A Multi-site, Placebo-controlled Study of Eszopiclone", "institution": "Rutgers, The State University of New Jersey", "dates": {"start": null, "completion": "2009-06"}, "summary": null}, "participants": null}, {"studyInfo": {"title": "Improving Sleep and Psychological Functioning in People With Depression and Insomnia", "institution": "Wake Forest University Health Sciences", "dates": {"start": null, "completion": "2008-12"}, "summary": null}, "participants": null}, {"studyInfo": {"title": "A Bioequivalence and Food Effect Study of SEP-190 in Japanese Healthy Subjects (Study SEP 190-102)", "institution": "Eisai Inc.", "dates": {"start": null, "completion": "2010-02"}, "summary": null}, "participants": null}, {"studyInfo": {"title": "Eszopiclone Treatment & Cortisol Responsivity", "institution": "Butler Hospital", "dates": {"start": null, "completion": "2009-08"}, "summary": null}, "participants": null}, {"studyInfo": {"title": "Safety and Efficacy of Chronic Hypnotic Use 2", "institution": "Henry Ford Health System", "dates": {"start": null, "completion": "2022-02"}, "summary": null}, "participants": [{"groupName": "Placebo", "dosage": 0, "size": null}, {"groupName": "Zolpidem CR", "dosage": 12.5, "size": null}, {"groupName": "Eszopiclone", "dosage": 3, "size": null}, {"groupName": "Total", "dosage": null, "size": null}]}, {"studyInfo": {"title": "Insomnia and Osteoarthritis Study", "institution": "Johns Hopkins University", "dates": {"start": null, "completion": "2013-12"}, "summary": null}, "participants": [{"groupName": "Eszopiclone", "dosage": 3, "size": null}, {"groupName": "Placebo", "dosage": 3, "size": null}, {"groupName": "Total", "dosage": null, "size": null}]}, {"studyInfo": {"title": "Eszopiclone for the Treatment of Posttraumatic Stress Disorder", "institution": "Rush University Medical Center", "dates": {"start": null, "completion": "2015-12"}, "summary": null}, "participants": [{"groupName": "Eszopiclone", "dosage": 3, "size": null}, {"groupName": "Placebo", "dosage": null, "size": null}, {"groupName": "Total", "dosage": null, "size": null}]}, {"studyInfo": {"title": "Mindfulness Versus Pharmacotherapy for Chronic Insomnia: A Pilot Study", "institution": "University of Minnesota", "dates": {"start": null, "completion": "2009-06"}, "summary": null}, "participants": [{"groupName": "Randomized to MBSR", "dosage": 0, "size": null}, {"groupName": "Randomized to PCT", "dosage": 0, "size": null}, {"groupName": "Total", "dosage": 0, "size": null}]}, {"studyInfo": {"title": "The Effects of Eszopiclone and Lexapro on Prefrontal Glutamate and GABA in Depression With Anxiety and Insomnia", "institution": "Steward St. Elizabeth's Medical Center of Boston, Inc.", "dates": {"start": null, "completion": "2011-07"}, "summary": null}, "participants": [{"groupName": "Eszopiclone", "dosage": 0, "size": null}, {"groupName": "Placebo", "dosage": 0, "size": null}, {"groupName": "Total", "dosage": 0, "size": null}]}]